Keith Thompson steps into CMO role at NuraLogix
November 3, 2021
TORONTO – Dr. Keith Thompson (pictured), a London-based family physician, has now taken on the role of chief medical officer (CMO) at NuraLogix, one of Canada’s fastest-rising tech companies.
In his 29-year medical career, Dr. Thompson has developed expertise in patient care as a family physician, growing his own practice over the years, and also getting involved in after hours care and walk-in clinic work.
Over this time, he became interested in the innovation technologies relevant to primary care. Dr. Thompson would describe his encounters with innovations as an “experience that has rekindled his passion for family medicine and patient-centered care.”
Dr. Thompson was one of the initial Canadian physicians hired to consult with the Teladoc/BestDoctors Canada start-up team in February of 2018. He was CMO for iTelemed, a nonprofit company innovating in virtual care programs within the public-funded health systems in Ontario.
He maintains an active networking relationship and advisory role with numerous health technology companies, both startups and established corporations.
He is a current member of the Primary Care Digital Health working group for the Western Ontario OHT, member of C.D. Howe Institute external reviews for virtual care, and member of Digital Health Canada.
NuraLogix is a research-based tech company that currently holds multiple patents and has conducted global clinical and research collaborations. Additionally, we have been featured in over 100 international media reports, as well as peer-reviewed papers and publications, including American Heart Association, Frontiers in Psychology, Scientific Reports, Springer Science, and The International Journal of Clinical Practice. Founded in Toronto in 2015, by Marzio Pozzuoli and Dr. Kang Lee, we have raised $20M+ in funds and currently employ 60 staff, ranging from neuroscientists to software engineers. For more information, visit www.nuralogix.ai.